Beyond BRCA: Exploring PARP Combinations in Prostate Cancer

Hear from the experts on how the latest clinical data from ASCO GU 2021 inform leveraging PARP inhibitor&ndash based combinations for treating prostate cancer with and without DNA damage repair alterations. Review their insights in clinical commentaries along with slides a podcast and on-demand Webcast adapted from a live CCO Webinar.

Share

Program Content

Activities

PARPi Combinations in Prostate Cancer
Beyond BRCA: Exploring PARP Combinations in Prostate Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 30, 2021

Expires: March 29, 2022

Activities

PARPi + ARi in mCRPC
PARP Combinations in Prostate Cancer: PARPi Plus Androgen Receptor Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 19, 2021

Expires: February 18, 2022

Other PARPi Combos in mCRPC
PARP Inhibitor Combinations in Prostate Cancer: Immune Checkpoint Inhibitors and Other Agents
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 19, 2021

Expires: February 18, 2022

Single Agent PARPi in mCRPC
Single-Agent PARP Inhibitors in Advanced Prostate Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 19, 2021

Expires: February 18, 2022

<i>EP</i>: PARPi Combos in PCa
ExpressPoints
Beyond BRCA: Exploring PARP Combinations in Prostate Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 03, 2021

Expires: March 02, 2022

Activities

Prostate Cancer PARPi Q&A
Expert Answers to Questions on PARP Inhibition for Prostate Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 06, 2021

Expires: April 05, 2022

Podcast Pearls: Prostate Cancer PARPi
Podcast Pearls: Expert Answers to Questions on PARP Inhibition for Prostate Cancer
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 06, 2021

Expires: April 05, 2022

Activities

PARPi Beyond mCRPC
PARP Inhibitors in Settings Beyond Metastatic Castration-Resistant Prostate Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 02, 2021

Expires: April 01, 2022

Faculty

cover img faculity

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Neal D. Shore, MD, FACS

Director
Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, South Carolina

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer TEXT Only